{"database": "lobbying", "table": "lobbying_activities", "rows": [[1695765, "9e80cdad-bce8-4036-bed9-bd6ab0547c53", "Q2", "POLICY DIRECTIONS INC.", 31747, "ENTERA HEALTH, INC.", 2015, "second_quarter", "MED", "Guidance on Investigational New Drug;\nOverall industry standards", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2015-07-15T11:09:03.803000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1695765"], "units": {}, "query_ms": 141.9986409600824, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}